Yahoo
HKSE - Delayed Quote HKD

Tianjin TEDA Biomedical Engineering Company Limited (8189.HK)

0.143 -0.010 (-6.54%)
At close: October 30 at 2:59:35 PM GMT+8
Chart Range Bar
Loading chart for 8189.HK
  • Previous Close 0.153
  • Open 0.150
  • Bid 0.138 x --
  • Ask 0.143 x --
  • Day's Range 0.138 - 0.150
  • 52 Week Range 0.114 - 0.405
  • Volume 365,000
  • Avg. Volume 1,051,774
  • Market Cap (intraday) 305.148M
  • Beta (5Y Monthly) -0.23
  • PE Ratio (TTM) --
  • EPS (TTM) -0.040
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Tianjin TEDA Biomedical Engineering Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of biological compound fertilizer products in the People's Republic of China. It operates through Fertiliser Products, and AI health & elderly care products and services segments. The company's biological compound fertilizer products include active fertilizer, mixture with nitrogen, phosphorus, and potassium with various formulas. It also involved in the provision of integrated elderly and health care; elderly equipment leasing services; elderly-related products sales; warehousing services; processing and licensing of the fertiliser products; sales of gold products for elderly customers, such as gold amulets and bracelets; sales of chips and servers supporting healthcare solutions; research and development of elderly care business; and elderly care consulting, advisory, management, and assessment services. In addition, the company provides and licenses electroencephalography photography (EEG) diagnosis detection services and conducts EEG detection and diagnosis technology services. Further, the company engages in the research, development, manufacture, and application of biomedical science and technology projects; regional soil resources conditioning and remediation research services; provision of soil environmental quality standards research services; development and application of AI medical large model and MaaS platform; AI life and health project expansion; and data cleaning, database, and data intelligence analysis full-process data services. Tianjin TEDA Biomedical Engineering Company Limited was incorporated in 2000 and is headquartered in Tianjin, the People's Republic of China.

bioteda.com

273

Full Time Employees

December 31

Fiscal Year Ends

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

8189.HK
54.60%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

8189.HK
64.25%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

8189.HK
55.43%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

8189.HK
48.93%
HANG SENG INDEX (^HSI)
8.21%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -12.52%

  • Return on Assets (ttm)

    -6.40%

  • Return on Equity (ttm)

    -140.82%

  • Revenue (ttm)

    592.59M

  • Net Income Avi to Common (ttm)

    -74.19M

  • Diluted EPS (ttm)

    -0.040

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    131.72M

  • Total Debt/Equity (mrq)

    399.30%

  • Levered Free Cash Flow (ttm)

    74.48M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: